In vitro anti-HSV-2 activity and mechanism of action of proanthocyanidin A-1 from Vaccinium vitis-idaea

Journal of the Science of Food and Agriculture

Volumn 85, Issue 1, 2005, Pages 10-15

  Cheng, Hua Yew ^a   Lin, Ta Chen ^b   Yang, Chien Min ^c   Shieh, Den En ^b   Lin, Chun Ching ^c  

^a TUNG FANG INSTITUTE OF TECHNOLOGY   (Taiwan)

^b TAJEN INSTITUTE OF TECHNOLOGY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Anti HSV 2 activity; Lingonberry; Proanthocyanidin A 1; Vaccinium vitis idaea Linn

Indexed keywords

ERICACEAE; HUMAN HERPESVIRUS 2; IDAEA; VACCINIUM VITIS-IDAEA; VITIS;

EID: 11244307471     PISSN: 00225142     EISSN: None     Source Type: Journal    
DOI: 10.1002/jsfa.1958     Document Type: Article

References (33)

1. Stang EJ, Weis GG and Klueh J, Lingonberry: potential new fruit for the northern United States, in Advances in New Crops, Ed by Janick J and Simon JE. Timber Press, Portland, OR, pp 321-323 (1990).
2. Holloway PF, Studies on vegetative and reproductive growth of lingonberry (Vaccinium vitis-idaea L). PhD Dissertation, University of Minnesota, St Paul, MN (1981).
3. Iwagaki H, Ishikawa S, Tamada T and Koike H, The present status of blueberry work and wild Vaccinium spp in Japan. Acta Hort 61:331-334 (1977).
4. Liebster G, Experimental and research work on fruit species of the genus Vaccinium in Germany. Acta Hort 61:19-24 (1977).
5. Müller HP, The use of Vaccinium fruit in the dairy industry. Acta Hort 61:343-347 (1977).
6. Racz G, Fuzi I and Fulop L, A method for determination of the arbutin content of cowberry leaves (Folium vitis-idaea). Rumanian Med Rev 6:88-90 (1962).
7. Render A, Manual of Cultivated Trees and Shrubs. Macmillan, New York (1940).
8. Whitley RJ, Kimberlin DW and Roizman B, Herpes simplex viruses. Clin Infect Dis 26:97-109 (1998).
9. Armstrong GL, Schillinger J, Markowitz L, Nahmias AJ, Johnson RE, McQuillan GM and St Louis ME, Incidence of herpes simplex virus type 2 infection in the United States. Am J Epidemiol 153:912-920 (2001).
10. Corey L, The current trend in genital herpes. Progress in prevention. Sex Transm Dis 21(2, Suppl):38-44 (1994).
11. Fleming DT, McQuillan GM, Johnson RE, Nahmias AJ, Aral SO, Lee FK and St Louis ME, Herpes simplex virus type 2 in the United States, 1976 to 1994. New Engl J Med 337:1105-1111 (1997).
12. Baringer RJ and Swoveland P, Recovery of herpes-simplex virus from human trigeminal ganglions. New Engl J Med 288:648-650 (1973).
13. Farnsworth NR, Ethnopharmacology and future drug development: the North American experience. J Ethnopharmacol 38:145-152 (1993).
14. Houghton PJ, The role of plants in traditional medicine and current therapy. J Altern Complement Med 1:131-143 (1995).
15. Morimoto S, Nonaka GI and Nishioka I, Tannins and related compounds. LX. Isolation and characterization of proanthocyanidins with a doubly-linked unit from Vaccinium vitis-idaea L. Chem Pharm Bull 36:33-38 (1988).
16. Weislow OS, Kiser R, Fine DL, Bader J, Shoemaker RH and Boyd MR, New soluble-formazan assay for HIV-1 cytopathic effects: application to high-flux screening of synthetic and natural products for AIDS-antiviral activity. J Natl Cancer Inst 81:577-586 (1989).
17. Cheng HY, Lin CC and Lin TC, Antiherpes simplex virus type 2 activity of casuarinin from the bark of Terminalia arjuna Linn. Antiviral Res 55:447-455 (2002).
18. Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tiemey S, Nofziger TH, Currens MJ, Seniff D and Boyd MR, Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 48:4827-4833 (1988).
19. Lin CC, Cheng HY, Yang CM and Lin TC, Antioxidant and antiviral activities of Euphorbia thymifolia L. J Biomed Sci 9:656-665 (2002).
20. Carlucci MJ, Ciancia M, Matulewicz MC, Cerezo AS and Damonte EB, Antiherpetic activity and mode of action of natural carrageenans of diverse structural types. Antiviral Res 43:93-102 (1999).
21. Boulware SL, Bronstein JC, Nordby EC and Weber PC, Identification and characterization of benzothiophene inhibitor of herpes simplex virus type 1 replication which acts at the immediate early stage of infection. Antiviral Res 51:111-125 (2001).
22. Logu AD, Loy G, Pellerano ML, Bonsignore L and Schivo ML, Inactivation of HSV-1 and HSV-2 and prevention of cell-to-cell virus spread by Santolina insularis essential oil. Antiviral Res 48:177-185 (2000).
23. Albin R, Chase R, Risano C, Lieberman M, Ferrari E, Skelton A, Buontempo P, Cox S, DeMartino J, Wright-Minogue J, Jirau-Lucca G, Kelly J, Afonso A, Kwong AD, Rozhon EJ and O'Connell JF, SCH 43478 and analogs: in vitro activity and in vivo efficacy of novel agents for herpesvirus type 2. Antiviral Res 35:139-146 (1997).
24. Rosenthal KS, Perez R and Hodnichak C, Inhibition of herpes simplex virus type 2 penetration by cytochalasins B and D. J Gen Virol 66:1601-1605 (1985).
25. Tal-Singer R, Peng C, Ponce De Leon M, Abrams WR, Banfield BW, Tufaro F, Cohen GH and Eisenberg RJ, Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules. J Virol 69:4471-4483 (1995).
26. Rajcani J and Vojvodova A, The role of herpes simplex virus glycoproteins in the virus replication cycle. Acta Virol 42:103-118 (1998).
27. Roizman B and Sears AE, Herpes simplex viruses and their replication, in Virology, Vol 2, 3rd edn, Ed by Fields BN, Knipe DM, Chanock RM, Hirsch MS, Melnick JL, Monath TP and Roizman B. Lippincott-Raven Publ, Philadelphia, PA, pp 2231-2295 (1996).
28. Spear PG, Entry of alphaherpesviruses into cells. Semin Virol 4:167-180 (1993).
29. Haslam E, Natural polyphenols (vegetable tannins) as drugs: possible modes of action. J Nat Prod 59:205-215 (1996).
30. Fine AM, Oligomeric proanthocyanidin complexes: history, structure, and phytopharmaceutical applications. Altern Med Rev 5:144-151 (2000).
31. De Bruyne T, Pieters L, Witvrouw M, De Clercq E, Berghe DV and Vlietinck AJ, Biological evaluation of proanthocyanidin dimers and related polyphenols. J Nat Prod 62:954-958 (1999).
32. Ho KY, Tsai CC, Huang JS, Lin TC, Hsu YF and Lin CC, Antioxidant activity of tannin compounds from Vaccinium vitis-idaea L. J Pharm Pharmacol 51:1075-1078 (1999).
33. Ho KY, Tsai CC, Huang JS, Chen CP, Lin TC and Lin CC, Antimicrobial activity of tannin components from Vaccinium vitis-idaea L. J Pharm Pharmacol 53:187-191 (2001).